Showing 861-870 of 1775 results for "".
Failing Sight Tied to Fall Risk
https://modernod.com/articles/significant-findings/failing-sight-tied-to-fall-risk/37766/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatIndustry Spotlight On Thomas Swinnen
https://modernod.com/topics/business/industry-spotlight-on-thomas-swinnen/38060/22. Prescribe Change and CONNECT with Patients
https://modernod.com/podcasts/four-eyes/22-prescribe-change-and-connect-with-patients/36972/We sit down with Dr. Steve Vargo to discuss his new book, Prescribing Change. The book's intention is to develop methods for optometrists to share information with their patients and have them ACT on it. We review his genius CONNECT method that navigates making connections with patients and influencNew Year, New Vision
https://modernod.com/topics/glaucoma/new-year-new-vision/54393/A Place for House Calls in Optometry
https://modernod.com/topics/patient-care/a-place-for-house-calls-in-optometry/38789/Consider delivering eye care where it’s needed most.Dupilumab–Associated Keratoconjunctivitis
https://modernod.com/topics/contact-lenses/dupilumab-associated-keratoconjunctivitis/38469/Find out how this biologic affected a patient’s scleral lens fit for pre-existing keratoconus and how his case was managed.What’s New in Contact Lenses
https://modernod.com/topics/contact-lenses/whats-new-in-contact-lenses-1/38238/A look at developments over the past year.Misleading Symptoms and Modern Vision
https://modernod.com/mod-issues/2018-julyy-aug/misleading-symptoms-and-modern-vision/39168/Our interactions with technology can have ocular consequences.TFOS DEWS III Published
https://modernod.com/podcasts/eyewire-news-the-podcast/tfos-dews-iii-published/37089/The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug B2. Myopia Control: Treatment Options and Upcoming Research
https://modernod.com/podcasts/four-eyes/2-myopia-control-treatment-options-and-upcoming-research/36952/We review treatment options related to myopia control including the new FDA approved lenses MiSight 1-Day by CooperVision, and share upcoming research in this area from Keyur Savla, BOptom and Celia Gong, OD.Resources:1. Review of Optometry Article on Myopia Treatments: https://www.reviewofoptometry